Quality of Life and Supportive Care in Multiple Myeloma

Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive...

Descripción completa

Detalles Bibliográficos
Autores principales: Cömert, Melda, Güneş, Ajda Ersoy, Şahin, Fahri, Saydam, Güray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878535/
https://www.ncbi.nlm.nih.gov/pubmed/24385802
http://dx.doi.org/10.4274/Tjh.2012.0192
_version_ 1782297823638716416
author Cömert, Melda
Güneş, Ajda Ersoy
Şahin, Fahri
Saydam, Güray
author_facet Cömert, Melda
Güneş, Ajda Ersoy
Şahin, Fahri
Saydam, Güray
author_sort Cömert, Melda
collection PubMed
description Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive treatment is an essential part of the therapeutic management of myeloma patients because it is directed towards improving the patient’s quality of life and also can improve survival. The aim of this review is to highlight the relationship among life of quality, supportive care, and improvement in survival. Conflict of interest:None declared.
format Online
Article
Text
id pubmed-3878535
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-38785352014-01-02 Quality of Life and Supportive Care in Multiple Myeloma Cömert, Melda Güneş, Ajda Ersoy Şahin, Fahri Saydam, Güray Turk J Haematol Review Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive treatment is an essential part of the therapeutic management of myeloma patients because it is directed towards improving the patient’s quality of life and also can improve survival. The aim of this review is to highlight the relationship among life of quality, supportive care, and improvement in survival. Conflict of interest:None declared. Galenos Publishing 2013-09 2013-09-05 /pmc/articles/PMC3878535/ /pubmed/24385802 http://dx.doi.org/10.4274/Tjh.2012.0192 Text en © Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Cömert, Melda
Güneş, Ajda Ersoy
Şahin, Fahri
Saydam, Güray
Quality of Life and Supportive Care in Multiple Myeloma
title Quality of Life and Supportive Care in Multiple Myeloma
title_full Quality of Life and Supportive Care in Multiple Myeloma
title_fullStr Quality of Life and Supportive Care in Multiple Myeloma
title_full_unstemmed Quality of Life and Supportive Care in Multiple Myeloma
title_short Quality of Life and Supportive Care in Multiple Myeloma
title_sort quality of life and supportive care in multiple myeloma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878535/
https://www.ncbi.nlm.nih.gov/pubmed/24385802
http://dx.doi.org/10.4274/Tjh.2012.0192
work_keys_str_mv AT comertmelda qualityoflifeandsupportivecareinmultiplemyeloma
AT gunesajdaersoy qualityoflifeandsupportivecareinmultiplemyeloma
AT sahinfahri qualityoflifeandsupportivecareinmultiplemyeloma
AT saydamguray qualityoflifeandsupportivecareinmultiplemyeloma

Ejemplares similares